APO Research
Talk to an analyst

APO RESEARCH · REPORT

DPT Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DPT Vaccines Industry Growth and Trends Forecast to 2032

21 December 202590 pages

Choose your research edition.

Industry ResearchDPT Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal DPT Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global DPT Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DPT Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DPT Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DPT Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DPT Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DPT Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DPT Vaccines Market by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

DPT Vaccines Segment by Type

DTaP

Tdap

DTwP

DPT Vaccines Segment by Age

12 Months Below

12 Months Above

DPT Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DPT Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DTaP Table 2. Major Company of Tdap Table 3. Major Company of DTwP Table 4. Global DPT Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 6. Global DPT Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global DPT Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global DPT Vaccines Price by Type (2021-2026) & (US$/Dose) Table 10. Global DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 11. Global DPT Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global DPT Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global DPT Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global DPT Vaccines Price by Type (2027-2032) & (US$/Dose) Table 15. North America DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 16. North America DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 18. Europe DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Asia-Pacific DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 22. Latin America DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 24. Middle East and Africa DPT Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. DPT Vaccines Industry Trends Table 26. DPT Vaccines Industry Drivers Table 27. DPT Vaccines Industry Opportunities and Challenges Table 28. DPT Vaccines Industry Restraints Table 29. Global DPT Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global DPT Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global DPT Vaccines Sales by Company (2021-2026) & (M Doses) Table 32. Global DPT Vaccines Sales Share by Company (2021-2026) Table 33. Global DPT Vaccines Market Price by Company (2021-2026) & (US$/Dose) Table 34. Global DPT Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global DPT Vaccines Major Company Production Sites and Headquarters Table 36. Global DPT Vaccines Company, Product Type & Application Table 37. Global DPT Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global DPT Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global DPT Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global DPT Vaccines Sales by Region (2021-2026) & (M Doses) Table 42. Global DPT Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global DPT Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global DPT Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 46. Global DPT Vaccines Sales by Region (2027-2032) & (M Doses) Table 47. Global DPT Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global DPT Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global DPT Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 51. Global DPT Vaccines Sales by Age (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 53. Global DPT Vaccines Sales Market Share in Volume by Age (2021-2026) Table 54. Global DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 55. Global DPT Vaccines Sales Market Share in Value by Age (2021-2026) Table 56. Global DPT Vaccines Price by Age (2021-2026) & (US$/Dose) Table 57. Global DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 58. Global DPT Vaccines Sales Market Share in Volume by Age (2027-2032) Table 59. Global DPT Vaccines Sales by Age (2027-2032) & (US$ Million) Table 60. Global DPT Vaccines Sales Market Share in Value by Age (2027-2032) Table 61. Global DPT Vaccines Price by Age (2027-2032) & (US$/Dose) Table 62. North America DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 63. North America DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 64. Europe DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 65. Europe DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 66. Asia-Pacific DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 67. Asia-Pacific DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 68. Latin America DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 69. Latin America DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 70. Middle East and Africa DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 71. Middle East and Africa DPT Vaccines Sales by Age (2021-2026) & (US$ Million) Table 72. Sanofi Pasteur Company Information Table 73. Sanofi Pasteur Business Overview Table 74. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Sanofi Pasteur DPT Vaccines Product Portfolio Table 76. Sanofi Pasteur Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. GSK DPT Vaccines Product Portfolio Table 81. GSK Recent Development Table 82. Mitsubishi Tanabe Pharma Company Information Table 83. Mitsubishi Tanabe Pharma Business Overview Table 84. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio Table 86. Mitsubishi Tanabe Pharma Recent Development Table 87. KM Biologics Company Information Table 88. KM Biologics Business Overview Table 89. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. KM Biologics DPT Vaccines Product Portfolio Table 91. KM Biologics Recent Development Table 92. Wuhan Institute of Biological Products Company Information Table 93. Wuhan Institute of Biological Products Business Overview Table 94. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio Table 96. Wuhan Institute of Biological Products Recent Development Table 97. Walvax Biotechnology Company Information Table 98. Walvax Biotechnology Business Overview Table 99. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. Walvax Biotechnology DPT Vaccines Product Portfolio Table 101. Walvax Biotechnology Recent Development Table 102. Chengdu Institute of Biological Products Company Information Table 103. Chengdu Institute of Biological Products Business Overview Table 104. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 105. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio Table 106. Chengdu Institute of Biological Products Recent Development Table 107. Minhai Biotechnology Company Information Table 108. Minhai Biotechnology Business Overview Table 109. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 110. Minhai Biotechnology DPT Vaccines Product Portfolio Table 111. Minhai Biotechnology Recent Development Table 112. North America DPT Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 113. North America DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 114. North America DPT Vaccines Sales Market Share by Country (2021-2026) Table 115. North America DPT Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 116. North America DPT Vaccines Sales Market Share Forecast by Country (2027-2032) Table 117. North America DPT Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America DPT Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 119. North America DPT Vaccines Market Share by Country (2021-2026) Table 120. North America DPT Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America DPT Vaccines Market Share Forecast by Country (2027-2032) Table 122. Europe DPT Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 123. Europe DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 124. Europe DPT Vaccines Sales Market Share by Country (2021-2026) Table 125. Europe DPT Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 126. Europe DPT Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. Europe DPT Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe DPT Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe DPT Vaccines Market Share by Country (2021-2026) Table 130. Europe DPT Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe DPT Vaccines Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific DPT Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 134. Asia-Pacific DPT Vaccines Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific DPT Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 136. Asia-Pacific DPT Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific DPT Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific DPT Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific DPT Vaccines Market Share by Country (2021-2026) Table 140. Asia-Pacific DPT Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific DPT Vaccines Market Share Forecast by Country (2027-2032) Table 142. Latin America DPT Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 143. Latin America DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 144. Latin America DPT Vaccines Sales Market Share by Country (2021-2026) Table 145. Latin America DPT Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 146. Latin America DPT Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America DPT Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America DPT Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America DPT Vaccines Market Share by Country (2021-2026) Table 150. Latin America DPT Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America DPT Vaccines Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa DPT Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 154. Middle East and Africa DPT Vaccines Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa DPT Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 156. Middle East and Africa DPT Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa DPT Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa DPT Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa DPT Vaccines Market Share by Country (2021-2026) Table 160. Middle East and Africa DPT Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa DPT Vaccines Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. DPT Vaccines Distributors List Table 165. DPT Vaccines Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. DPT Vaccines Image Figure 2. Global DPT Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global DPT Vaccines Sales (2021-2032) & (M Doses) Figure 5. DTaP Image Figure 6. Global DTaP Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Tdap Image Figure 8. Global Tdap Sales YoY Growth (2021-2032) & (M Doses) Figure 9. DTwP Image Figure 10. Global DTwP Sales YoY Growth (2021-2032) & (M Doses) Figure 11. Global DPT Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global DPT Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America DPT Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America DPT Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe DPT Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe DPT Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific DPT Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America DPT Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America DPT Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa DPT Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa DPT Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. 12 Months Below Image Figure 26. Global 12 Months Below Sales YoY Growth (2021-2032) & (M Doses) Figure 27. 12 Months Above Image Figure 28. Global 12 Months Above Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Global DPT Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global DPT Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America DPT Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America DPT Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe DPT Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe DPT Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific DPT Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America DPT Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America DPT Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa DPT Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa DPT Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 42. North America DPT Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America DPT Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. Europe DPT Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe DPT Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Asia-Pacific DPT Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific DPT Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Latin America DPT Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America DPT Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Middle East and Africa DPT Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa DPT Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. DPT Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. DPT Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • DTaP
  • Tdap
  • DTwP
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Chengdu Institute of Biological Products
  • Minhai Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DPT Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DPT Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DPT Vaccines Market by Type
  6. 1.3.1 DTaP
  7. 1.3.2 Tdap
  8. 1.3.3 DTwP
  9. 1.4 Global DPT Vaccines Market Size by Type
  10. 1.4.1 Global DPT Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global DPT Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global DPT Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America DPT Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe DPT Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific DPT Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America DPT Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa DPT Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DPT Vaccines Industry Trends
  2. 2.2 DPT Vaccines Industry Drivers
  3. 2.3 DPT Vaccines Industry Opportunities and Challenges
  4. 2.4 DPT Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DPT Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by DPT Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by DPT Vaccines Price (2021-2026)
  4. 3.4 Global DPT Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DPT Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global DPT Vaccines Company, Product Type & Application
  7. 3.7 Global DPT Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DPT Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DPT Vaccines Tier 1, Tier 2, and Tier 3
4 DPT Vaccines Regional Status and Outlook
  1. 4.1 Global DPT Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DPT Vaccines Historic Market Size by Region
  3. 4.2.1 Global DPT Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DPT Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DPT Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DPT Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global DPT Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DPT Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DPT Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DPT Vaccines by Application
  1. 5.1 DPT Vaccines Market by Age
  2. 5.1.1 12 Months Below
  3. 5.1.2 12 Months Above
  4. 5.2 Global DPT Vaccines Market Size by Age
  5. 5.2.1 Global DPT Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global DPT Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global DPT Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Age
  9. 5.3.1 North America DPT Vaccines Sales Breakdown by Age (2021-2026)
  10. 5.3.2 Europe DPT Vaccines Sales Breakdown by Age (2021-2026)
  11. 5.3.3 Asia-Pacific DPT Vaccines Sales Breakdown by Age (2021-2026)
  12. 5.3.4 South America DPT Vaccines Sales Breakdown by Age (2021-2026)
  13. 5.3.5 Middle East and Africa DPT Vaccines Sales Breakdown by Age (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi Pasteur
  2. 6.1.1 Sanofi Pasteur Company Information
  3. 6.1.2 Sanofi Pasteur Business Overview
  4. 6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
  6. 6.1.5 Sanofi Pasteur Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK DPT Vaccines Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Mitsubishi Tanabe Pharma
  14. 6.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 6.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
  18. 6.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 6.4 KM Biologics
  20. 6.4.1 KM Biologics Company Information
  21. 6.4.2 KM Biologics Business Overview
  22. 6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 KM Biologics DPT Vaccines Product Portfolio
  24. 6.4.5 KM Biologics Recent Developments
  25. 6.5 Wuhan Institute of Biological Products
  26. 6.5.1 Wuhan Institute of Biological Products Company Information
  27. 6.5.2 Wuhan Institute of Biological Products Business Overview
  28. 6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
  30. 6.5.5 Wuhan Institute of Biological Products Recent Developments
  31. 6.6 Walvax Biotechnology
  32. 6.6.1 Walvax Biotechnology Company Information
  33. 6.6.2 Walvax Biotechnology Business Overview
  34. 6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
  36. 6.6.5 Walvax Biotechnology Recent Developments
  37. 6.7 Chengdu Institute of Biological Products
  38. 6.7.1 Chengdu Institute of Biological Products Company Information
  39. 6.7.2 Chengdu Institute of Biological Products Business Overview
  40. 6.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
  42. 6.7.5 Chengdu Institute of Biological Products Recent Developments
  43. 6.8 Minhai Biotechnology
  44. 6.8.1 Minhai Biotechnology Company Information
  45. 6.8.2 Minhai Biotechnology Business Overview
  46. 6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
  48. 6.8.5 Minhai Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America DPT Vaccines Sales by Country
  2. 7.1.1 North America DPT Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DPT Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America DPT Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America DPT Vaccines Market Size by Country
  6. 7.2.1 North America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DPT Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America DPT Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DPT Vaccines Sales by Country
  2. 8.1.1 Europe DPT Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DPT Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe DPT Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DPT Vaccines Market Size by Country
  6. 8.2.1 Europe DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DPT Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe DPT Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DPT Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific DPT Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DPT Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DPT Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DPT Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DPT Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DPT Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DPT Vaccines Sales by Country
  2. 10.1.1 South America DPT Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DPT Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America DPT Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America DPT Vaccines Market Size by Country
  6. 10.2.1 South America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DPT Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America DPT Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DPT Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa DPT Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DPT Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DPT Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DPT Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DPT Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DPT Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DPT Vaccines Value Chain Analysis
  2. 12.1.1 DPT Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DPT Vaccines Production Mode & Process
  7. 12.2 DPT Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DPT Vaccines Distributors
  10. 12.2.3 DPT Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst